SCHEMBL6159800

SCHEMBL6159800

O=C1[N]N(C2CCNCC2)C(c2ccncc2)=C1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
FSCN1 Q16658 1/20 0.35
MAPK13 O15264 2/20 0.35
MAPK12 P53778 2/20 0.35
MAPK11 Q15759 2/20 0.35
MAPK14 Q16539 2/20 0.35
SLC6A2 P23975 5/20 0.34
SLC6A4 P31645 5/20 0.34
SLC6A3 Q01959 5/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
METAP2 P50579 1/20 0.33
AKT1 P31749 1/20 0.33
GSK3B P49841 1/20 0.33
CHRM1 P11229 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159161 0.87 KCNH2 (0.38) MAPK13MAPK12MAPK11MAPK14AKT1
SCHEMBL6160893 0.75 HTR6 (0.37) MAPK13MAPK12MAPK11MAPK14AKT1
SCHEMBL5215378 0.71 MAPK14 (0.39) NPY5RCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6160345 0.70 NR3C1 (0.37) CYP2D6MAPK13MAPK12MAPK11MAPK14
SCHEMBL6164467 0.69 RIPK3 (0.40) MAPK11MAPK14CHRM1PLAT
SCHEMBL6160896 0.68 NPY5R (0.44) NPY5RCYP3A4MAPK13MAPK12MAPK11
SCHEMBL12326458 0.63 CHRNB2 (0.43) CYP3A4CYP2D6CYP2C9CYP2C19FSCN1
SCHEMBL3962464 0.63 DRD2 (0.45) SLC6A2SLC6A4SLC6A3CHRM1
Hydrochloric Acid SCHEMBL2430559 0.62 CHRNB2 (0.42) CYP3A4CYP2D6CYP2C9CYP2C19FSCN1
SCHEMBL4030612 0.62 MAPK14 (0.69) NPY5RMAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1542680-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS Amgen Inc. (US) 2005-06-22 EP claimed
WO-2004022055-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2004-03-18 WO claimed
EP-1542680-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS Amgen Inc. (US) 2005-06-22 EP disclosed
WO-2004022055-A1 1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2004-03-18 WO disclosed